Drug
Samarium-153 clinical trials
A product of Samarium; its studies count on that page too.
- studies test it
- 4
- open now
- 0
- in phase 3
- 1
- first study started
- 2003
How studies write it
Studies that test it under each name
Name
Other names
Studies by the year they started
4 studies that test it; most in 2006 (2)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2006 | 2 |
| 2008 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 2
- Phase 3
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 4
Radiation Therapy Oncology Group (2) · Sidney Kimmel Cancer Center at Thomas Jefferson University (1) · New York Presbyterian Brooklyn Methodist Hospital (1)
Studies
Open first, then newest update. How each study uses Samarium-153 is read from its arms, and is right about nine times in ten.
Testing it · 4
- Samarium-153 With Neoadjuvant Hormonal and Radiation Therapy for Locally Advanced Prostate CancerCompletedPhase 1Sidney Kimmel Cancer Center at Thomas Jefferson UniversityNCT00328614Written as Samarium-153
- Zoledronate, Vitamin D, and Calcium With or Without Strontium 89 or Samarium 153 in Preventing or Delaying Bone Problems in Patients With Bone Metastases From Prostate Cancer, Lung Cancer, or Breast CancerCompletedPhase 3Radiation Therapy Oncology GroupNCT00365105Written as Sm-153
- Effect of Samarium on the Relief of Pain Due to Vertebral MetastasesCompletedPhase 1/2New York Presbyterian Brooklyn Methodist HospitalNCT00374751Written as Samarium (153SM)
- Samarium Sm 153 Lexidronam Pentasodium and 3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Rising Prostate-Specific Antigen Levels After Radical Prostatectomy for Prostate CancerCompletedPhase 2Radiation Therapy Oncology GroupNCT00551525Written as Samarium 153
Codes
What other systems call Samarium-153 · ClinicalTrials.gg INT000623
- MeSH (NLM) C000615023Samarium-153One source NLM
- UNII (FDA) 6Q1KA41UWMSAMARIUM SM-153Confirmed FDA, NLM, Wikidata
- RxNorm 196342Confirmed FDA, Wikidata
- Wikidata Q1878279samarium-153Confirmed FDA, NLM, Wikidata
- DrugBank DB12905One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000615023 | Samarium-153 | One source NLM |
| UNII (FDA) | 6Q1KA41UWM | SAMARIUM SM-153 | Confirmed FDA, NLM, Wikidata |
| RxNorm | 196342 | — | Confirmed FDA, Wikidata |
| Wikidata | Q1878279 | samarium-153 | Confirmed FDA, NLM, Wikidata |
| DrugBank | DB12905 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.